Featured Research

from universities, journals, and other organizations

Type 2 diabetes decision support tool available

Date:
June 15, 2011
Source:
Keele University
Summary:
A new computerized prescribing decision support tool – designed to assist in the guidance for the management of type 2 diabetes in adults in primary care – is now available to UK healthcare professionals.

A new computerised prescribing decision support tool -- designed to assist in the implementation of NICE guidance1,2 for the management of type 2 diabetes in adults in primary care -- is now available free to UK healthcare professionals.

Related Articles


Developed at the Department of Medicines Management, Keele University, the user-friendly software delivers individualised prescribing recommendations by cross-referencing patient profiles with multiple treatment algorithms that are built upon NICE guidance. In practice, the practitioner is prompted with a series of multiple choice and closed questions enabling the tool to create an individual patient profile. The application interrogates the treatment algorithms, and generates an appropriate patient-tailored treatment recommendation. The tool also provides the rationale behind each recommendation, supporting references and related NICE guidance, important management considerations, common treatment side-effects, drug costs and associated recommendations on the management of blood pressure and lipids.

Professor Stephen Chapman, Professor of Prescribing Studies at Keele University said: "With both recent NICE guidance and the growing number of anti-diabetes agents at our disposal we anticipate that this intuitive tool will easily guide the prescriber through what may otherwise be an ever more complex evidence base."

The tool is also designed to support the consultation process through the use of a novel diabetes 'dashboard' visual aid, the incorporation of the UKPDS risk engine and a personalised patient printout summarising the consultation.

Once installed, the tool is kept up-to-date via automatic online updates.

The Type 2 Diabetes Management Decision Support Tool was developed by Medicines Management, Keele University with the support of a financial grant provided by Takeda UK Ltd. Takeda's only involvement has been financial. Takeda reviewed the tool for technical accuracy but had no editorial control. The development and content of the tool is the sole responsibility of Medicines management, Keele University.


Story Source:

The above story is based on materials provided by Keele University. Note: Materials may be edited for content and length.


Cite This Page:

Keele University. "Type 2 diabetes decision support tool available." ScienceDaily. ScienceDaily, 15 June 2011. <www.sciencedaily.com/releases/2011/06/110615120121.htm>.
Keele University. (2011, June 15). Type 2 diabetes decision support tool available. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2011/06/110615120121.htm
Keele University. "Type 2 diabetes decision support tool available." ScienceDaily. www.sciencedaily.com/releases/2011/06/110615120121.htm (accessed March 3, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 3, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com
Going Gluten-Free Could Get You A Tax Break

Going Gluten-Free Could Get You A Tax Break

Newsy (Mar. 2, 2015) If a doctor advises you to remove gluten from your diet, you could get a tax deduction on the amount you spend on gluten-free foods. Video provided by Newsy
Powered by NewsLook.com
GlaxoSmithKline and Novartis Try Swapping Success

GlaxoSmithKline and Novartis Try Swapping Success

Reuters - Business Video Online (Mar. 2, 2015) GlaxoSmithKline and Novartis have completed a series of asset swaps worth more than $20 billion. As Grace Pascoe reports they say the deal will reshape both drugmakers. Video provided by Reuters
Powered by NewsLook.com
How Can West Africa Rebuild After Ebola?

How Can West Africa Rebuild After Ebola?

Reuters - Business Video Online (Mar. 2, 2015) How best to rebuild the three West African countries struggling with Ebola will be discussed in Brussels this week. As Hayley Platt reports Sierra Leone has the toughest job ahead - its once thriving economy has been ravaged by the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins